Balakrishnan VS, Coles GA, Williams JD. A potential role for endogenous adenosine in the control of human glomerular and tubular function. Am J Physiol Renal Fluid Electrolyte Physiol. 1993;34:F504-F510.
Balakrishnan VS, Coles GA, Williams JD. The effects of intravenous adenosine on renal function in healthy human subjects. Am J Physiol Renal Fluid Electrolyte Physiol 1996;40:F374-F381.
Balakrishnan VS, Coles GA, Williams JD. Functional role of endogenous adenosine in human chronic renal disease. Experimental Nephrology, Vol.4: 26-36, 1996.
Balakrishnan VS, von Ruhland CJ, Coles GA, Williams JD. The effects of adenosine-A1 receptor blockade in a rat model of cyclosporin A nephrotoxicity. Br J Pharmacol. 1996;117:879-84.
Balakrishnan VS, Jaber BL, Natov SN, Cendoroglo M, King AJ, Schmid CH, Pereira BJ. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients. Kidney Int. 1998;54: 2106-12.
Balakrishnan VS, Schmid CH, Jaber BL, Natov SN, King AJ, Pereira BJG. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells: a novel predictor of morbidity among hemodialysis patients. J Am Soc Nephrol. 2000;11:2114-21.
Rao M, Guo D, Jaber BL, Sundaram S, Cendoroglo M, King AJ, Pereira BJG, Balakrishnan VS and the HEMO Study Group. Dialyzer membrane type and reuse practice influence polymorphonuclear cell function in hemodialysis patients. Kidney Int 2004;65:682-91.
Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King AJ, Pereira BJG. Cytokine gene polymorphisms in hemodialysis: association with comorbidity, functionality and serum albumin. Kidney Int 2004;65:1449-60.
Rao M, Guo D, Jaber BL, Tighiouart H, Pereira BJG, Balakrishnan VS. Transforming growth factor-beta1 gene polymorphisms and prevalence of vascular disease in hemodialysis patients. Kidney Int 2004;66:419-27.
Rao M, Guo D, Perianayagam MC, Tighiouart, MC, Jaber BL, Pereira BJ, Balakrishnan VS, The HEMO Study Group. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patient. Am J Kidney Dis 2005;45:324-33.
Perianayagam MC, Morena M, Jaber BL, Balakrishnan VS. Antioxidants reverse uremia-induced down-regulation of mitochondrial membrane potential and interleukin-10 production. Eur J Clin Invest. 2005;35:148-53.
Rao M, Li L, Tighiouart H, Jaber BL, Pereira BJ, Balakrishnan VS. Plasma adiponectin levels and clinical outcomes among hemodialysis patients. Nephrol Dial Transplant. 2008 Aug;23(8):2619-28.
Rao M, Li L, Demello C, Guo D, Jaber BL, Pereira BJG, Balakrishnan VS. Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol. 2009 Jan;20(1):189-96.
Balakrishnan VS, Rao M, Menon V, Gordon P L, Pilichowska M, Castaneda F, Castaneda-Sceppa C. Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease. Clin J Am Soc Nephrol, May 2010.